Dong Liang
- Molecular Biology top 5%
- Biomedical Engineering top 2%
- Materials Chemistry top 5%
- Biomaterials top 1%
- Cancer Research top 2%
- Co-authors
- Chun LiMin ZhouMei TianWei LüRui ZhangMiao HuangMarites P. MelanconXifeng Wu
- Topics
- Nanoplatforms for cancer theranostics (8 papers)Nanoparticle-Based Drug Delivery (8 papers)Pharmacogenetics and Drug Metabolism (6 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Dong Liang
133 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Molecular Biology 1.6k
- Biomedical Engineering 1.4k
- Materials Chemistry 898
- Biomaterials 860
- Cancer Research 650
Countries citing papers authored by Dong Liang
This map shows the geographic impact of Dong Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Liang more than expected).
Fields of papers citing papers by Dong Liang
This network shows the impact of papers produced by Dong Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Liang. The network helps show where Dong Liang may publish in the future.
Co-authorship network of co-authors of Dong Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Dong Liang. A scholar is included among the top collaborators of Dong Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Liang. Dong Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 12 | |
| 9 | 6 | |
| 10 | 7 | |
| 11 | 5 | |
| 12 | 6 | |
| 13 | 46 | |
| 14 | PTPN9 induces cell apoptosis by mitigating the activation of Stat3 and acts as a tumor suppressor in colorectal cancer | 2 |
| 15 | 2 | |
| 16 | 50 | |
| 17 | 10 | |
| 18 | 102 | |
| 19 | 9 | |
| 20 | Preparation and characters of chitosan-g-salicylic acid | 1 |
About Dong Liang
Dong Liang is a scholar working on Pharmacology, Transplantation and Geriatrics and Gerontology, having authored 140 papers that have together received 4.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). The work is most often cited by research in Biomaterials (860 citations), Cancer Research (650 citations) and Biomedical Engineering (1.4k citations). Dong Liang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Chun Li, Min Zhou, Mei Tian, Wei Lü, Rui Zhang, Miao Huang, Marites P. Melancon, Xifeng Wu, Qian Huang and Shaoli Song. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.